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Introduction
Primary systemic amyloidosis (AL), a plasma cell dyscra-
sia, is often associated with a fatal outcome if there is
advanced cardiac involvement. Myocardial delayed
enhancement (DE) has been reported on cardiac MRI but
the functional significance of such finding is not estab-
lished.
Purpose
Our aim is to determine the functional significance of
myocardial delayed enhancement (DE) on MRI by com-
paring systolic and diastolic function of AL patients with
delayed enhancement (DE+) versus those without (DE-)
using MRI and echocardiography.
Methods
23 patients (11 females; 61 ± 10 years) with biopsy-
proven AL were grouped into DE+ (N = 17, 74%) and DE-
(N = 6, 26%). Left ventricular ejection fraction (LVEF) and
diastolic function (early diastolic filling rate DFR and
early diastolic filling volume 1/3 FF on MRI, and ratio of
early transmitral inflow to mitral annular velocity E/Em
and deceleration time DT on echo) were compared. Auto-
mated simple linear curve fitting of early (first 1/3) diasto-
lic filling curve was used to calculate DFR (slope of curve)
and 1/3 FF was filling volume of first 1/3 of diastole.
Results
LVEF (DE+ vs. DE-: 67.3 ± 17 vs. 68.8 ± 12%, p = NS) was
similar. However, DFR (1.7 ± 2 vs. 5.4 ± 3% enddiastolic
volume/% cardiac cycle, p = 0.04, Figure 1) and 1/3 FF
(19.8 ± 13 vs. 36.3 ± 23% enddiastolic volume, p = 0.03)
were lower in DE+ patients. E/Em was higher in DE+
patients (17.4 ± 9 vs. 7.9 ± 3, p = 0.02) while DT was
shorter (219 ± 62 vs. 288 ± 64 ms, p = 0.03). There was a
nonsignificant trend towards reduced survival in DE+ sub-
jects (304 ± 273 vs. 560 ± 280 days, p = 0.07, Figure 2).
Conclusion
Delayed enhancement, present in 74% of AL patients, is
associated with significant diastolic dysfunction and may
be important for noninvasive evaluation of primary amy-
loidosis.
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The functional significance of delayed enhancement in pri-
mary systemic amyloidosis is not defined. We found amyloid 
patients with delayed enhancement on MRI have significant 
diastolic dysfunction compared to those without.
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